Vishakha Kumar

Overview

Explore the profile of Vishakha Kumar including associated specialties, affiliations and a list of published articles.

Snapshot

Articles 14

Citations 542

Followers 0

Related Specialties

Critical Care

General Medicine

Pediatrics

Top 10 Co-Authors

Rahul Kashyap

Ognjen Gajic

Allan Walkey

Aysun Tekin

Vikas Bansal

Karen Boman

Zaw Myo Tun

Clarence C Tam

Amy B Christie

Neha Deo

Published In

Crit Care Med

Int J Infect Dis

JMIR Res Protoc

Pharmacotherapy

Arch Bronconeumol

Affiliations

Soon will be listed here.

Recent Articles

The association between early corticosteroid use and the risk of secondary infections in hospitalized patients with COVID-19: a double-edged sword. Results from the international SCCM discovery viral infection and respiratory illness universal study...

Bansal V, Jain N, Lal A, Khedr A, Tekin A, Jama A, et al.

Front Med (Lausanne) . 2025 Mar; 12:1466346. PMID: 40027890

Background: Corticosteroids improve survival in hospitalized COVID-19 patients needing supplemental oxygen. However, concern exists about increased risk of secondary infections. This study investigated the impact of early corticosteroids use on...

Development of a Core Critical Care Data Dictionary With Common Data Elements to Characterize Critical Illness and Injuries Using a Modified Delphi Method

Murphy D, Anderson W, Heavner S, Al-Hakim T, Cruz-Cano R, Laudanski K, et al.

Crit Care Med . 2025 Feb; PMID: 39982128

Objectives: To develop the first core Critical Care Data Dictionary (C2D2) with common data elements (CDEs) to characterize critical illness and injuries. Design: Group consensus process using modified Delphi approach....

The Association of Asthma and Metabolic Dysfunction With Outcomes of Hospitalized Patients With COVID-19

Vukoja M, Tekin A, Parada N, Gray J, Mallouhi A, Roddy T, et al.

J Allergy Clin Immunol Pract . 2024 May; 12(9):2390-2398.e7. PMID: 38796103

Background: There have been conflicting results on the association of asthma with the severity of coronavirus disease 2019 (COVID-19). Poor metabolic health has been previously associated with both severe COVID-19...

Variation in Sedative and Analgesic Use During the COVID-19 Pandemic and Associated Outcomes

Rucci J, Law A, Bolesta S, Quinn E, Garcia M, Gajic O, et al.

CHEST Crit Care . 2024 Apr; 2(1). PMID: 38576856

Background: Providing analgesia and sedation is an essential component of caring for many mechanically ventilated patients. The selection of analgesic and sedative medications during the COVID-19 pandemic, and the impact...

Coronavirus Disease 2019 in Pediatric Oncology Patients: A Matched-Cohort Analysis of the SCCM Discovery Viral Infection and Respiratory Illness Universal Study COVID-19 Registry

Balakumar N, Catueno S, Nadiger M, Keshavamurthy P, Totapally B, Sherani F, et al.

J Pediatr Hematol Oncol . 2023 Feb; 45(3):e309-e314. PMID: 36729758

Background: There is a paucity of multicenter data describing the impact of coronavirus disease 2019 (COVID-19) on hospitalized pediatric oncology patients. Using a large, multicenter, Society of Critical Care Medicine...

Pre-hospital Aspirin Use and Patient Outcomes in COVID-19: Results from the International Viral Infection and Respiratory Illness Universal Study (VIRUS)

Lal A, Domecq Garces J, Bansal V, Tekin A, Zec S, Khanna A, et al.

Arch Bronconeumol . 2022 Sep; 58(11):746-753. PMID: 36153214

Introduction: The goal of this investigation is to assess the association between prehospital use of aspirin (ASA) and patient-centered outcomes in a large global cohort of hospitalized COVID-19 patients. Methods:...

SARS-CoV-2 With Concurrent Respiratory Viral Infection as a Risk Factor for a Higher Level of Care in Hospitalized Pediatric Patients

Dikranian L, Barry S, Ata A, Chiotos K, Gist K, Bhalala U, et al.

Pediatr Emerg Care . 2022 Aug; 38(9):472-476. PMID: 36040468

Objective: As of early 2021, there have been over 3.5 million pediatric cases of SARS-CoV-2, including 292 pediatric deaths in the United States. Although most pediatric patients present with mild...

Admission Code Status and End-of-life Care for Hospitalized Patients With COVID-19

Kiker W, Cheng S, Pollack L, Creutzfeldt C, Kross E, Curtis J, et al.

J Pain Symptom Manage . 2022 Jun; 64(4):359-369. PMID: 35764202

Context: The COVID-19 pandemic has highlighted variability in intensity of care. We aimed to characterize intensity of care among hospitalized patients with COVID-19. Objectives: Examine the prevalence and predictors of...

Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19: A retrospective cohort analysis from 28 U.S. Hospitals

Harthan A, Nadiger M, McGarvey J, Hanson K, Gharpure V, Bjornstad E, et al.

Pharmacotherapy . 2022 Jun; 42(7):529-539. PMID: 35661394

Objectives: Suggested therapeutic options for Multisystem Inflammatory Syndrome in Children (MIS-C) include intravenous immunoglobulins (IVIG) and steroids. Prior studies have shown the benefit of combination therapy with both agents on...

10.

Public acceptability of COVID-19 control measures in Singapore, Hong Kong, and Malaysia: A cross-sectional survey

Voo T, Ballantyne A, Jenn Ng C, Cowling B, Xiao J, Phang K, et al.

Int J Infect Dis . 2022 Apr; 120:51-58. PMID: 35430376

Background: Several countries have implemented control measures to limit SARS-CoV-2 spread, including digital contact tracing, digital monitoring of quarantined individuals, and testing of travelers. These raise ethical issues around privacy,...